Open Access Open Access  Restricted Access Subscription Access

Pharmacogenomics: The Intersection of Genomics, Pharmacology, and Clinical Medicine

Niranjan Giri, Quadri. M. Soheb, Umesh Maske, Mayur Katode

Abstract


Pharmacogenomics, the study of how genetic variations affect an individual's response to drugs, has emerged as a crucial field in modern medicine. By integrating genomics, pharmacology, and clinical medicine, pharmacogenomics aims to personalize treatment strategies, improve drug efficacy, and reduce adverse reactions. This review article provides an overview of the current state of pharmacogenomics, highlighting its applications in clinical practice, drug development, and precision medicine. We discuss the key concepts, methodologies, and technologies driving the field, including genome-wide association studies, next generation sequencing, and machine learning algorithms. Furthermore, we examine the challenges and opportunities in translating pharmacogenomics research into clinical practice, including the need for standardized guidelines, regulatory frameworks, and education for healthcare professionals. By exploring the intersection of genomics, pharmacology, and clinical medicine, this article aims to provide a comprehensive understanding of pharmacogenomics and its potential to transform the way we approach patient care.


Full Text:

PDF

References


National Institutes of Health (NIH). (2020). Pharmacogenomics: A Guide to Genomic Medicine. Retrieved from https://www.nih.gov/news-events/nih- researchmatters/january2020/ Pharmacogenomics.htm

Food and Drug Administration (FDA). (2020). Pharmacogenomics: A New Frontier in Drug Development. Retrieved from https://www.fda.gov/drugs/science-and- researchdrugs/ pharmacogenomics-new-frontier-drug-development

American Medical Association (AMA). (2019). Pharmacogenomics: A Guide for Physicians. Retrieved from https://www.ama-assn.org/delivering-care/pharmacogenomics-guide- physicians

Nature Reviews Genetics. (2020). Pharmacogenomics: From Bench to Bedside. Retrieved from https://www.nature.com/articles/s41576-020-0214-4

Journal of Clinical Pharmacology. (2019). Pharmacogenomics: A Review of the Current State of the Field. Retrieved from https://jcp.sagepub.com/doi/abs/10.1177/0091270018814144

de Leon, J., Susce, M. T., & Murray-Carmichael, E. (2006). The AmpliChip CYP450 test: A new tool for personalized medicine. Molecular Diagnosis & Therapy, 10(2), 135144.

Kalow, W. (1962). Pharmacogenetics: Heredity and the response to drugs. W.B. Saunders Company.

Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., & Riordan, J. R. (1987). The mdr1 gene, responsible for multidrug resistance, codes for Pglycoprotein. Biochemical and Biophysical Research Communications, 141(3), 956-962.

Vogel, F. (1959). Moderne Probleme der Humangenetik. Ergebnisse der Inneren Medizin und Kinderheilkunde, 12, 52-125.

Weinshilboum, R. M. (2003). Inheritance and drug response. New England Journal of Medicine, 348(6), 529-537. doi: 10.1056/NEJMra021151


Refbacks

  • There are currently no refbacks.